February marks Rare Disease Month, a time to reflect on the more than 300 million people worldwide living with a rare disease.1 For many, that diagnosis comes after years of uncertainty. The journey is often marked by delays, misdiagnosis, isolation, and a frustrating lack of information or treatment options.
Despite the name, rare diseases are not rare in impact. With over 7,000 known rare conditions, rare disease affects 1 in 10 people in the United States. That’s more than cancer and HIV combined.1,2 And yet awareness, support, and infrastructure often lag far behind.
So, during Rare Disease Month—and especially on Rare Disease Day (February 28)—we’re called to do more than raise awareness. We’re called to rethink how the healthcare system sees and supports those living with rare conditions.
The Journey Is Rare. The Challenges Are Not
A rare diagnosis often starts with confusion. Symptoms don’t follow familiar patterns. Referrals bounce between specialists. Answers come slowly, if at all. On average, it takes 4 to 5 years to receive an accurate rare disease diagnosis.3
But the challenges don’t stop there. Even after diagnosis, patients and caregivers face uncertainty around:
- Treatment options, which may be unavailable, unaffordable, or off label
- Insurance coverage, which rarely accounts for rare complexity
- Emotional toll, as support networks are often small or nonexistent
- Stigma, especially for conditions that aren’t immediately visible
And for healthcare providers, there’s the challenge of limited experience, incomplete data, and lack of consensus on treatment pathways. The system is simply not built for the uncommon.
Why Awareness Isn’t Enough
Raising visibility for rare diseases is essential, but it’s not the end goal. Awareness without understanding can still lead to inertia. What rare disease communities need are systems and solutions designed with their lived experiences in mind.
That includes:
- Better diagnostics and earlier screening
- Education for providers who may only encounter a condition once in their careers
- Communication that reflects the realities of patients and caregivers, rather than general assumptions
- Support structures that go beyond treatment access to address quality of life, emotional health, and daily function
Rare disease patients are often left to become their own advocates, educators, and care coordinators. The burden of visibility should not fall on those already carrying so much.
Reframing Rare Disease Through Behavior, Empathy, and Design
Solving the issues around rare disease requires more than clinical breakthroughs. It requires reframing the way we approach health communication, support systems, and experience design.
Because the system wasn’t built with rare in mind, we must rethink it from the ground up—guided not only by data, but by lived experience. That starts with asking the right questions:
- What do people believe about their condition, and how can we help reframe that belief?
- Where do trust gaps exist in the system, and how do we close them?
- What emotional frictions hold people back from seeking care, staying adherent, or advocating for more?
Answering these questions requires listening deeply, designing for specificity, and applying empathy with discipline—not as sentiment, but as strategy.
Our Commitment at GSW
At GSW, we’ve worked in the rare disease space for over a decade, with more than 20% of our work in the past five years focused on helping rare disease brands connect with the people who need them most.
We approach rare disease not just as a market, but as a mission—one that demands curiosity, creativity, and constant rethinking. Through behavioral science, omnichannel design, and strategy rooted in real human experience, we aim to move people toward understanding, belief, and action.
Because in the rare disease space communication isn’t just about information. It’s about hope, clarity, and connection.
This Month and Every Month We Wonder More
Rare Disease Month is a powerful reminder: just because something is rare doesn’t mean it’s not everywhere. The impact is real. The urgency is high. And the potential for better is within reach—if we choose to see it, hear it, and act on it.
At GSW, Wonder More is more than a tagline. It’s a way of thinking. A belief that progress starts with curiosity—and that asking better questions leads to better answers. It means being open: to listening, to learning, and to building something better, together.
Because in rare disease, as in all of health, solutions start not with certainty, but with the courage to wonder what else is possible.
Sources:
- World Health Organization. Rare diseases: a global health priority for equity and inclusion. Agenda item 13.3. Presented at: Seventy-eighth World Health Assembly; May 27, 2025; Geneva, Switzerland. Accessed February 9, 2026. https://apps.who.int/gb/ebwha/pdf_files/WHA78/A78_R11-en.pdf
- Rare Disease Facts. Global Genes: Allies in Rare Disease. Accessed February 9, 2026. https://globalgenes.org/rare-disease-facts/
- Phillips C, Parkinson A, Namsrai T, et al. Time to diagnosis for a rare disease: managing medical uncertainty. A qualitative study. Orphanet J Rare Dis. 2024;19(1):297. https://doi.org/10.1186/s13023-024-03319-2
